Hereditary angioedema (HAE) is a rare disorder characterized by recurrent episodes of severe swelling throughout various regions of the body. HAE typically is inherited in an autosomal-dominant pattern, although some cases occur spontaneously. HAE affects 1 in every 50,000 individuals.1 The 3 types of HAE can be differentiated by serum levels of the C1-esterase inhibitor…
Hereditary angioedema (HAE) is a genetic disease characterized by the development of vasogenic edema, in which an accumulation of extravascular fluid in diverse tissues is caused by a non-inflammatory, non-allergic process. HAE is estimated to affect between 1 in 10,000 and 1 in 150,000 people. Clinical features include swelling of sudden onset around the eyes,…
Hereditary angioedema (HAE) is a rare autosomal dominant condition that can present in 3 types. The most common is type 1, which involves a deficiency in C1 inhibitor (C1INH) protein. Type 2 is associated with dysfunctional C1INH. The rarest form is type 3, which shows normal C1INH levels and function. Hereditary angioedema is associated with…
Hereditary angioedema (HAE), a genetic disorder inherited in an autosomal-dominant pattern, is characterized by severe swelling in the limbs, face, intestinal tract, and airways.1 In retrospective studies, researchers tracked down in church records from the 17th century what they believed to be the first documented cases of hereditary angioedema, describing “hereditary periodic edema” in a…
Hereditary angioedema (HAE) is a rare genetic condition that is inherited in an autosomal dominant pattern. It is defined by recurrent episodes of fluid accumulation outside blood vessels, resulting in the rapid swelling of tissues in the hands, feet, limbs, face, intestinal system, and airways.1,2 HAE is classified into 2 types: HAE with a deficiency…
Hereditary angioedema (HAE) is a rare genetic condition characterized by attacks of cutaneous and submucosal edema. These debilitating episodes typically affect the abdominal area, upper respiratory tract, and skin, and they have a significant impact on quality of life.1,2 In addition to preventing mortality, HAE management aims to reduce morbidity, providing patients with a better…
Multiple sclerosis (MS) is a neurological disorder characterized by the demyelination of the brain and spinal cord due to the immune system attacking the myelin, which surrounds and protects the nerve fibers. This demyelination impedes the conduction of signals between the brain and the body. Symptoms include muscle weakness, visual dysfunction, cognitive problems, lack of…
Multiple sclerosis (MS) is an autoimmune neurological disorder affecting the central nervous system that is characterized by progressive damage to myelin, a fatty coating surrounding the nerves. Myelin protects the nerves from damage and allows for faster communication between the brain and the rest of the body.1 Disruption of signal conduction between the brain and…
The term gastrointestinal stromal tumor (GIST) was coined in 1983 by Mazur and Clark when they studied the histological origins of these tumors, found in the interstitial cells of Cajal.1 The interstitial cells of Cajal are specialized pacemaker nerve cells of the sympathetic nervous system which drive the rhythmic, peristaltic activity of the intestinal smooth…
Systemic mastocytosis is a rare hematological disease characterized by the overproliferation of mast cells, white blood cells that originate in the bone marrow, throughout the connective tissues of multiple organ systems, including the liver, spleen, bones, lymph nodes, lungs, and digestive system.1 Mast cells are activated by environmental triggers, including insect stings, animal bites, temperature…
